title: Toxicologic evaluation of tungsten: 28-day inhalation study of tungsten blue oxide in rats.
abstract: The toxicity and toxicokinetics of tungsten blue oxide (TBO) were examined. TBO is an intermediate in the production of tungsten powder, and has shown the potential to cause cellular damage in in vitro studies. However, in vivo evidence seems to indicate a lack of adverse effects. The present study was undertaken to address the dearth of longer-term inhalation toxicity studies of tungsten oxides by investigating the biological responses induced by TBO when administered via nose-only inhalation to rats at levels of 0.08, 0.325, and 0.65 mg TBO/L of air for 6 h/day for 28 consecutive days, followed by a 14-day recovery period. Inhaled TBO was absorbed systemically and blood levels of tungsten increased as inhaled concentration increased. Among the tissues analyzed for tungsten levels, lung, femur and kidney showed increased levels, with lung at least an order of magnitude greater than kidney or femur. By exposure day 14, tungsten concentration in tissues had reached steady-state. Increased lung weight was noted for both terminal and recovery animals and was attributed to deposition of TBO in the lungs, inducing a macrophage influx. Microscopic evaluation of tissues revealed a dose-related increase in alveolar pigmented macrophages, alveolar foreign material and individual alveolar foamy macrophages in lung. After a recovery period there was a slight reduction in the incidence and severity of histopathological findings. Based on the absence of other adverse effects, the increased lung weights and the microscopic findings were interpreted as nonadverse response to exposure and were not considered a specific reaction to TBO.
authors.affiliation: Illinois Institute of Technology Research Institute, Chicago, USA. nrajendran@iitri.org
authors.forename: Narayanan
authors.initials: N
authors.lastname: Rajendran
authors.forename: Shu-Chieh
authors.initials: SC
authors.lastname: Hu
authors.forename: Dennis
authors.initials: D
authors.lastname: Sullivan
authors.forename: Miguel
authors.initials: M
authors.lastname: Muzzio
authors.forename: Carol J
authors.initials: CJ
authors.lastname: Detrisac
authors.forename: Carmen
authors.initials: C
authors.lastname: Venezia
mesh_terms: D000336:Aerosols; D000818:Animals; D019540:Area Under Curve; D015415:Biomarkers / Q000097:blood / Q000652:urine; D005260:Female; D005269:Femur / Q000378:metabolism; D005487:Foam Cells / Q000187:drug effects / Q000276:immunology / Q000378:metabolism; D006207:Half-Life; D019570:Inhalation Exposure; D007668:Kidney / Q000378:metabolism; D008168:Lung / Q000187:drug effects* / Q000276:immunology / Q000378:metabolism / Q000473:pathology; D016676:Macrophages, Alveolar / Q000187:drug effects / Q000276:immunology / Q000378:metabolism; D008297:Male; D008657:Metabolic Clearance Rate; D010087:Oxides / Q000097:blood / Q000493:pharmacokinetics / Q000633:toxicity*; D010316:Particle Size; D052638:Particulate Matter / Q000097:blood / Q000493:pharmacokinetics / Q000633:toxicity*; D051381:Rats; D017207:Rats, Sprague-Dawley; D018570:Risk Assessment; D014018:Tissue Distribution; D014414:Tungsten / Q000097:blood / Q000493:pharmacokinetics / Q000633:toxicity*
chemical_list: D000336:Aerosols; D015415:Biomarkers; D010087:Oxides; D052638:Particulate Matter; C511604:tungsten oxide; D014414:Tungsten